Regenerx Biopharmaceuticals Inc

CIK 707511 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Regenerx Biopharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Aug 14, 202315-12G0001104659-23-091294
Aug 7, 20238-K0001104659-23-088321
Jul 11, 2023DEF 14A0001104659-23-080025
Jul 10, 20238-K0001104659-23-079709
Jul 6, 202340001213900-23-055186
Jul 6, 2023SC 13D/A0001213900-23-055191
Jun 26, 2023PRE 14A0001104659-23-074370
Jun 21, 20238-K0001104659-23-072992
May 15, 202310-Q0001410578-23-001223
Apr 11, 202310-K0001410578-23-000628
Apr 3, 2023NT 10-K0001104659-23-040936
Nov 14, 202210-Q0001410578-22-003350
Aug 12, 202210-Q0001410578-22-002406
May 19, 202240001437749-22-013090
May 19, 202240001437749-22-013085
May 19, 202240001437749-22-013083
May 19, 202240001437749-22-013098
May 19, 202240001437749-22-013094
May 19, 202240001437749-22-013095
May 16, 202210-Q0001410578-22-001705
Mar 30, 202210-K0001104659-22-040167
Mar 2, 202240001437749-22-005012
Nov 17, 2021424B30001104659-21-140353
Nov 15, 20218-K0001104659-21-139018
Nov 15, 202110-Q0001104659-21-139207